Advanced search
Publication Cover
Emerging Therapeutic Targets Volume 4, 2000 - Issue 1
Journal homepage
19
Views
0
CrossRef citations to date
0
Altmetric
Review

Emerging therapeutic targets in paediatric kidney diseases

Hannu Sariola Institute of Biotechnology, PO Box 56, Viikinkaari 9, FIN-00014 University of Helsinki, Finland. [email protected]
&
Hannu Jalanko Hospital for Children and Adolescents, University of Helsinki, FIN-00029 Helsinki, Finland. E-mail: [email protected]
Pages 29-38 | Published online: 25 Feb 2005

Bibliography

  • BARASCH J, YANG J, WARE B et al.: Mesenchymal to epithelial conversion in rat metanephros is induced by LIF. Cell (1999) 99:377–386.
  • ••A recent breakthrough in the identification of inducers of thedifferentiation of the nephrons.
  • BARD J, DAVIES J, KARAVANOVA I, LEHTONEN E, SARIOLA H, VAINIO S: Kidney development: the inductive interactions. Semin. Cell Devel. Biol. (1996) 7:195–202.
  • LECHNER MS, DRESSLER GR: The molecular basis ofembryonic kidney development. Mech. Devel. (1997) 62:105–120.
  • DAVIES JA, BARD JBL: The development of the kidney. Curr. Topic. Dev. Biol. (1998) 39:245–301.
  • HERZLINGER D, QIAO J, COHEN D, RAMAKRISHNA N, BROWN AM: Induction Of kidney epithelial morpho-genesis by cells expressing Wnt-1. Devel. Biol. (1994) 166:815–818.
  • •First experimental study showing that Wnt-proteins are important in kidney morphogenesis.
  • DAVIES JA, GARROD DR: Induction of early stages of kidney tubule differentiation by lithium ions. Devel. Biol. (1995) 167(1):50–60.
  • •First successful experiment to induce kidney morpho-genesis chemically.
  • KARAVANOVA ID, DOVE LF, RESAU JH, PERANTONI AO:Conditioned medium from a rat ureteric bud cell line in combination with bFGF induces complete differen-tiation of isolated metanephric mesenchyme. Develop-ment (1996) 122:4159–4167.
  • KISPERT A, VAINIO S, MCMAHON AP: Wnt-4 is amesenchymal signal for epithelial transformation of metanephric mesenchyme in the developing kidney. Development (1998) 125:4225–4234.
  • STARK K, VAINIO S, VASSILEVA G, MCMAHON AP: Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature (1994) 372:679–683.
  • SARIOLA H, SAINIO K: Tip-top branching ureteric bud. Curr. Opin. Cell Biol. (1997) 9:877–884.
  • SAINIO K, SUVANTO P, DAVIES J et al.: Glial cellline-derived neurotrophic factor is required for bud initiation from ureteric epithelium. Development (1997) 124:4077–4087.
  • •A detailed in vitro study on the role of GDNF in kidney morphogenesis, showing also the requirement of other molecules in ureteric branching.
  • TROWERS PR, WOOLF AS, HARDMAN P: Glial cell line-derived neurotrophic factor stimulates ureteric bud outgrowth and enhances survival of ureteric bud cells in vitro. Exp. Nephrol. (1998) 6:337–351.
  • LIN L-FH, DOHERTY DH, LILE JD, BEKTESH S, COLLINS F: GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science (1993) 260:1130–1132.
  • ••Primary characterisation of GDNF.
  • OPPENHEIM RW, HOUENOU LJ, JOHNSON JE et al.: Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature (1995) 373:344–346.
  • KOTZBAUER PT, LAMPE PA, HEUCKEROTH RO et al.: Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature (1996) 384:467–470.
  • ••Primary characterisation of neurturin.
  • MILBRANDT J, DE SAUVAGE FJ, FAHRNER TJ et al.: Persephin, a novel neurotrophic factor related to GDNF and neurturin. Neuron (1998) 20:245–253.
  • ••Primary characterisation of persephin.
  • BALOH RH, TANSEY MG, LAMPE PA et al.: Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRa3-Ret receptor complex. Neuron (1998) 21:1291–1302.
  • ••Primary characterisation of artemin.
  • SAARMA M, SARIOLA H: Other neurotrophic factors:Glial cell line-derived neurotrophic factor (GDNF). Microsc. Res. Tech. (1999) 45:292–302.
  • DURBEC P, MARCOS-GUTIERREZ V, KILKENNY C et al.: GDNF signalling through the Ret receptor tyrosine kinase. Nature (1996) 381:789–793.
  • ••Identification of R et as a signalling receptor for GDNF.
  • TRUPP M, ARENAS E, FAINZILBER M et al.: Functional receptor for GDNF encoded by the cRet proto-oncogene. Nature (1996) 381:785–789.
  • ••Identification of R et as a signalling receptor for GDNF.
  • VEGA QC, WORBY CA, LECHNER MS, DIXON JE, DRESSLER GR: Glial cell line-derived neurotrophic factor activates the receptor tyrosine kinase ret and promotes kidney morphogenesis. Proc. Nati Acad. Sci. USA (1996) 93:10657–10661.
  • ••Identification of R et as a signalling receptor for GDNF.
  • TREANOR JJ, GOODMAN L, DE SAUVAGE F et al.: Charac-terization of a multicomponent receptor for GDNF. Nature (1996) 382:80–83.
  • ••Identification of R et as a signalling receptor for GDNF.
  • SCHUCHARDT A, D'AGATI V, LARSSON-BLOMBERG L, COSTANTINI F, PACHNIS V: Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature (1994) 367:380–383.
  • •The phenotypes of GDNF-, GFRal-and Ret-deficient mice are amazingly similar (references 24–28).
  • PICHEL JG, SHEN L, SHENG HZ et al.: Defects in entericinnervation and kidney development in mice lacking GDNF. Nature (1996) 382:73–76.
  • MOORE MW, KLEIN RD, FARINAS I et al.: Renal andneuronal abnormalities in mice lacking GDNF. Nature (1996) 382:76–79.
  • SANCHEZ MP, SILOS-SANTIAGO I, FRISEN J, HE B, LIRASA, BARBACID M: Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature (1996) 382:70–73.
  • CACALANO G, FARINA I, WANG L et al: Ulla1 is anessential receptor component for GDNF in the developing nervous system and kidney. Neuron (1998) 21:53–62.
  • JING S, WEN D, YU Y et al.: GDNF-induced activation of the Ret protein tyrosine kinase is mediated by GDNFR-a, a novel receptor for GDNF. Cell (1996) 85:1113–1124.
  • •Primary characterisation of a co-receptor for RET, GDNFR-a, that is now called GDNF family receptor a-1.
  • WOOLF AS, KOLATSI-JOANNOU M, HARDMAN P et al: Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros. J. Cell Biol. (1995) 128:171–184.
  • SANFORD L, ORMSBY I, GITTENBERGER DE GROOT A et al.: Transforming growth factor 132 (TGF62) knockout mice have multiple developmental defects that are non-overlapping with other TGF 6 knockout phenotypes. Development (1997) 124:2659–2670.
  • MULLER U, WANG D, DENDA S, MENESIS J, PEDERSEN R, REICHARDT L: Integrin a861 is critically important for epithelial-mesenchymal interactions during kidney morphogenesis. Cell (1997) 88:603–613.
  • ••A very selective renal phenotype.
  • HOLMBERG C, JALANKO H, TRYGGVASON K, RAPOLA J: Congenital nephrotic syndrome. In: Paediatric Nephrology (Edition 3). Holliday MA, Barratt T, Avner E, (Eds.), Williams and Wilkins, Baltimore, USA (1998):765–777.
  • KESTILA M, LENKKERI U, MANNIKKO M et al.: Position-ally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. MoL Cell 1998 1:575–582.
  • ••Primary characterisation of nephrin.
  • LENKKERI U, MANNIKKO M, MCCREADY P et al.: Structure of the gene for congenital nephrotic syndrome of the Finnish type (NPHS1) and characteri-zation of mutations. Am] Hum. Genet. (1999) 64:51–61.
  • RUOTSALAINEN V, LJUNGBERG P, WARTIOVAARA J et al:Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc. Natl. Acad. Sci. USA (1999) 96:7962–7967.
  • TRYGGVASON K: Unravelling the mechanisms of theglomerular ultrafiltration: Nephrin, a key component of the slit diaphragm. J. Am. Soc. Nephrol. (1999) 10:2440–2445.
  • IMAI E, ISAKA Y: Strategies of gene transfer to the kidney. Kidney Int. (1998) 53(2) :26 4–272
  • MET C, XU H: ICAM-1 antisense DNA protects renal function against ischemia-reperfusion injury in rats. J. Am. Soc. Nephrol. (1999) 10:448A.
  • KLUTH DC, REES AJ: New approaches to modify glomerular inflammation. J. Nephrol. (1999) 12:66–75.
  • AINSLEY C, KLUTH D, PEARCE W, RESS A: Use of geneti-cally modified macrophages to deliver TGF-61 to inflamed glomeruli. J. Am. Soc. Nephrol. (1999) 10:445A.
  • KLUTH D, PEARCE W, FINLAY S, ANEGON I, REES A: Interleukin-4 gene therapy using adenoviral transfected macrophages in nephrotoxic nephritis. J. Am. Soc. Nephrol (1999) 10:445A.
  • BUDISAVLJEVIC M, FULMER J, SELF S et al.: Atrial natriuretic peptide gene delivery attenuates mesangial cell proliferation in anti-Thyl nephritis. J. Am. Soc. Nephrol. (1999) 10:446A.
  • BORDER WA, NOBLE NA, YAMAMOTO T et al: Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature (1992) 360:361–364.
  • ••A classic study showing the role of TGFI3–1 in thepathogenesis of (experimental) glomerulonephritis.
  • LIPKOWITZ M, BRUGGEMAN L, OLLER S, RAPPAPORT J, KLOTMAN P, KLOTMAN M: Intra-uretral delivery of recombinant adeno-associated virus (rAAV) vectors results in long-term expression in the kidney. J. Am. Soc. Nephrol (1999) 10:447A.
  • ANTIGNAC C, ARDUY C, BECKMANN J: A gene for familial juvenile nephronophtisis (recessive medullary cystic kidney disease) maps to chromo-some 2p. Nature Genet. (1993) 3:342–345.
  • HILDEBRANDT F, OTTO E, LESCHER B, RENSING C, KISPERT A: Nephrocystin: gene expression and evolutionary conservation between human, mouse and C. elegans. J. Am. Soc. Nephrol. (1999) 10:448A.
  • ORELLANA S, AVNER ED: Cystic maldevelopment of the kidney. Sem. Nephrol (1995) 15:341–352.
  • ARNOULD T, KIM E, TSIOKAS L et al: The polycystic kidney disease 1 gene product mediates protein kinase c-dependent and c-Jun n-terminal kinase-dependent activation of the transcription factor AP-1. J. Biol. Chem. (1998) 273:6013–6018.
  • CALVET JP: Molecular genetics of polycystic kidney disease. J. Nephrol. (1998) 11:24–34.
  • SULLIVAN LP, WALLACE DP, GRANTHAM JJ: Chloride and fluid secretion in polycystic kidney disease. J. Am. Soc. Nephrol. (1998) 9:903–916.
  • TSIOKAS L, KIM E, ARNOULD T, SUKHATME VP, WALZ G: Homo-and heterodimeric interactions between the gene products of PKD1 and PKD2. Proc. Natl. Acad. Sci. USA (1997) 94:6965–6970.
  • DU J, WILSON PD: Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD. Am. J. PhysioL (1995) 269:C487–495.
  • SWEENEY WE, AVNER ED: Functional activity of epidermal growth factor receptors in autosomal recessive polycystic kidney disease. Am. J. Physiol (1998) 44:F387–F394.
  • RICHARDS WG, SWEENEY WE, YODER BK, WILKINSON JE, WOYCHIK RP, AVNER ED: Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease. J. Clin. Invest. (1998) 101:935–939.
  • •Experimental evidence for the EGFR activity in the progres-sion of cysts in PKD.
  • MIETTINEN PJ, BERGER JE, MENESES J et al: Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature (1995) 376:337–341.
  • DRESSLER G, WOOLF AS: Pax2 in development and renal disease. Int. J. Devel Biol. (1999) 43:463–468.
  • KIM E, ARNOULD T, SELLIN LK et al.: The polycystic kidney disease 1 gene product modulates Wnt signaling. J. Biol. Chem. (1999) 274:4947–4953.
  • PUGH J, SWEENEY WE, AVNER ED: The tyrosine kinase activity of the EGF receptor in murine metanephric organ culture. Kidney Int. (1995) 47:774–781.
  • AVNER ED, SWEENEY WE, WOYCHIK RP: Inhibition of epidermal growth factor receptor activity modulates collecting tubule cystogenesis in vitro. J. Am. Soc. Nephrol. (1995) 6:690.
  • LEVITZKI A: Tyrphostins: tyrosine kinase blockers as novel antiproliferative agents and dissectors of signal transduction. FASEB (1992) 6:3275–3282.
  • ARMSTRONG JF, PRITCHARD-JONES K, BICKMORE WA, HASTIE ND, BARD JBL: The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo. Mech. Develop. (1992) 40:85–97.
  • KREIDBERG JA, SARIOLA H, LORING JM et al.: WT-1 is required for early kidney development. Cell (1993) 74:679–691.
  • LEE, SB, HUANG K, PALMER R et al.: The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin. Cell (1999) 98:663–673.
  • ••An elegant microarray-based screening for the genesregulated by WT1.
  • SCHMIDT L, DUH FM, CHEN F: Germline and somatic mutations in the tyrosine kinase domain of the Met protooncogene in papillary renal carcinoma. Nature Genet. (1997) 16:68–73.
  • •A straightforward study pointing out the role of Met proto-oncogene in the pathogenesis of renal carcinoma.
  • DUAN DR, PAUSE A, BURGESS WH et al.: Inhibition of transcription elongation by the VHL tumour suppressor. Science (1995) 269:1402–1406.
  • FLEMING S: Renal cancer genetics: von Hippel Lindauand other syndromes. Int. J. Devel. Biol. (1999) 43:469–472.
  • SIEMEISTER G, WINDEL K, MOHRS K, BARLEON B, MARTINY-BYRON G, MARME D: Reversion of deregu-lated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel Lindau tumor suppressor protein. Cancer Res. (1996) 56:2299–2301.
  • GNARRA JR, WARD JM, PORTER FD et al.: Defectiveplacental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc. Nati Acad. Sci. USA (1997) 94:9102–9107.

Websites

  • http://www.ana.ed.ac.uk/anatomy/database/kidbase/kidh ome.html DAVIES JA, BRANDLI AW: The Kidney Development Database'
  • •A very useful Internet database for all who work with nephrogenesis or kidney diseases.
  • http://www.ncbi.nlm.nih.gov/htbin-post/Omim/dispmim? 301050 Alport syndrome.
  • http://www.ncbi.nlm.nih.gov/htbin-post/Omim/dispmim? 256300 Congenital nephrosis.
  • http://www.ncbi.nlm.nih.gov/htbin-post/Omim/dispmim? 174000 Nephronophtisis.
  • http://www.ncbi.nlm.nih.gov/htbin-post/Omim/dispmim? 603860 Nephronophtisis.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.